-
A novel ANO3 variant associated with generalized dystonia in an elderly woman
-
A novel GRM1 variant associated with autosomal dominant cerebellar ataxia (ADCA)
-
A novel tele-rehabilitation program aimed at reducing fall risk in Parkinson’s Disease patients
-
A novel variant [c.2974G>A; (p.Asp992Asp)] of DYT/PARK-ATP1A3
-
A Pandemic Care Partner Summit: Online Program Helps Parkinson’s Care Partners Take Positive Actions
-
A perception of knowledge on Parkinson’s disease among University students
-
A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson’s Disease Dementia.
-
A phase 2b randomized, double-blind, placebo-controlled study of suvecaltamide in the treatment of adults with moderate to severe essential tremor: study design and methodology
-
A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia
-
A phase IV, randomized, double-blind cross-over study comparing the clinical safety, efficacy and duration of abobotulinumtoxinA with onabotulinumtoxinA in adults with upper-limb spasticity: The DIRECTION study
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- …
- 132
- Next Page »